India to United States: Trastuzumab Export Trade Route
India has recorded 26 verified shipments of Trastuzumab exported to United States, representing a combined trade value of $3.0M USD. This corridor is served by 5 active Indian exporters, with an average shipment value of $115.0K USD. The leading Indian exporter is BIOCON BIOLOGICS INDIA LIMITED, which accounts for 98% of total export value with 6 shipments worth $2.9M USD. On the buying side, XXOSIXXLARXXNEWXX LIXXTED is the largest importer in United States with $2.9M USD in purchases. The top 3 suppliers — BIOCON BIOLOGICS INDIA LIMITED, LOKA BIOSCIENCES PRIVATE LIMITED, INTAS PHARMACEUTICALS LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Trastuzumab corridor is one of India's established pharmaceutical export routes, with 26 shipments documented worth a combined $3.0M USD. The route is dominated by BIOCON BIOLOGICS INDIA LIMITED, which alone accounts for roughly 98% of all export value, reflecting the consolidated nature of India's trastuzumab manufacturing sector.
Across 5 active suppliers, the average shipment value stands at $115.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with trastuzumab's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 11.1%, placing it at rank #18 among India's top trastuzumab export destinations globally.
On the import side, key buyers of Indian trastuzumab in United States include XXOSIXXLARXXNEWXX LIXXTED, KBDNA INC, PROLYNX INC and 6 others. XXOSIXXLARXXNEWXX LIXXTED is the single largest importer with 5 shipments valued at $2.9M USD.
Route Characteristics
- Average transit15 days
- Peak seasonQ1
- Primary modeSea freight
- Top portAHEMDABAD AIR
Market Position
- Global rank#18
- Annual growth+11.1%
- Demand growth+11.8%
- Regulatory ease71/100
Top 10 Indian Trastuzumab Exporters to United States
Showing top 10 of 5 Indian suppliers exporting Trastuzumab to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | BIOCON BIOLOGICS INDIA LIMITED Avg $488.3K per shipment | 6 | $2.9M | 97.9% |
| 2 | LOKA BIOSCIENCES PRIVATE LIMITED Avg $30.5K per shipment | 2 | $60.9K | 2.0% |
| 3 | INTAS PHARMACEUTICALS LIMITED Avg $15 per shipment | 16 | $236 | 0.0% |
| 4 | KEMWELL BIOPHARMA PRIVATE LIMITED Avg $150 per shipment | 1 | $150 | 0.0% |
| 5 | ESR ENTERPRISES Avg $48 per shipment | 1 | $48 | 0.0% |
This table shows the top 10 of 5 Indian companies exporting trastuzumab to United States, ranked by total trade value. The listed exporters are: BIOCON BIOLOGICS INDIA LIMITED, LOKA BIOSCIENCES PRIVATE LIMITED, INTAS PHARMACEUTICALS LIMITED, KEMWELL BIOPHARMA PRIVATE LIMITED, ESR ENTERPRISES. BIOCON BIOLOGICS INDIA LIMITED is the dominant supplier with 6 shipments worth $2.9M USD, giving it a 98% market share. The top 3 suppliers together account for 100% of the total trade value on this route.
Top 10 Trastuzumab Importers in United States
Showing top 10 of 9 known buyers in United States receiving Trastuzumab shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian trastuzumab in United States include XXOSIXXLARXXNEWXX LIXXTED, KBDNA INC, PROLYNX INC, CHARLES RIVER LABORATORIES, INC., CHARLES RIVER LABORATORIES INC, among 9 total buyers. The largest importer is XXOSIXXLARXXNEWXX LIXXTED, accounting for $2.9M USD across 5 shipments — representing 98% of all trastuzumab imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | XXOSIXXLARXXNEWXX LIXXTED | 5 | $2.9M | 97.9% |
| 2 | KBDNA INC | 2 | $60.9K | 2.0% |
| 3 | PROLYNX INC | 1 | $150 | 0.0% |
| 4 | CHARLES RIVER LABORATORIES, INC. | 3 | $140 | 0.0% |
| 5 | CHARLES RIVER LABORATORIES INC | 3 | $73 | 0.0% |
| 6 | YUKO LTO | 1 | $48 | 0.0% |
| 7 | CHARLES RIVER LABORATORIES | 3 | $23 | 0.0% |
| 8 | Biocon Biologics Inc | 1 | $9 | 0.0% |
| 9 | BIOPHARMA SPEC INC | 7 | $0 | 0.0% |
Top 10 Trastuzumab Formulations Imported by United States
Showing top 10 of 24 product formulations shipped on the India to United States Trastuzumab route, ranked by trade value
United States imports a wide range of trastuzumab formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — OGIVRI 420 TRASTUZUMAB — accounts for $2.1M USD across 3 shipments. There are 24 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | OGIVRI 420 TRASTUZUMAB | 3 | $2.1M | 69.6% |
| 2 | OGIVRI TM TRASTUZUMAB | 1 | $620.3K | 20.7% |
| 3 | OGIVRI 150 TRASTUZUMAB | 1 | $228.9K | 7.7% |
| 4 | TRASTUZUMAB (440 MG VIAL)(NET WEIGHT OF | 1 | $30.5K | 1.0% |
| 5 | TRASTUZUMAB (440 MG VIAL)(QTY:114 VIALS) | 1 | $30.5K | 1.0% |
| 6 | TRASTUZUMAB 440 MG WITH 2 WFI VIALS FORRECONSTITUTION | 1 | $150 | 0.0% |
| 7 | VIVITRA 150 VIAL TRASTUZUMAB .PHARMACEUTIAL MEDICINES | 1 | $48 | 0.0% |
| 8 | TRASTUZUMAB (CHINESE HAMSTER-CRICETULUSGRISEUS OVARY CELLS) (B.NO:P62-CI-0009)MFG. DATE : MAR-24 & EXP. DATE : N/A | 1 | $47 | 0.0% |
| 9 | TRASTUZUMAB (CHINESE HAMSTER-CRICETULUSGRISEUS OVARY CELLS) (B.NO:P62-CI-0010)MFG. DATE : MAR-24 & EXP. DATE : N/A | 1 | $47 | 0.0% |
| 10 | TRASTUZUMAB (CHINESE HAMSTER-CRICETULUSGRISEUS OVARY CELLS) (B.NO:P23.1-BM-0014MFG. DATE : MAR-24 & EXP. DATE : N/A | 1 | $47 | 0.0% |
Showing top 10 of 24 Trastuzumab formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 70%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
AHEMDABAD AIR handles the highest volume with 12 shipments. Transit time averages 15 days by sea.
Market Dynamics
India's trastuzumab exports to United States are driven primarily by a handful of large-scale manufacturers. BIOCON BIOLOGICS INDIA LIMITED with 6 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — BIOCON BIOLOGICS INDIA LIMITED, LOKA BIOSCIENCES PRIVATE LIMITED, INTAS PHARMACEUTICALS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $115.0K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as ogivri tm trastuzumab and ogivri 150 trastuzumab, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, XXOSIXXLARXXNEWXX LIXXTED is the largest importer with 5 shipments worth $2.9M USD — representing 98% of all trastuzumab imports from India on this route. A total of 9 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $3.0M
- Avg. Shipment
- $115.0K
- Suppliers
- 5
- Buyers
- 9
- Transit (Sea)
- ~15 days
- Annual Growth
- +11.1%
Related Analysis
Reverse Direction
United States → India — Trastuzumab (Import)Other Trastuzumab Routes
Unlock the Full India to United States Trastuzumab Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 26 shipments on this route.
Frequently Asked Questions — India to United States Trastuzumab Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Trastuzumab to United States?
The leading Indian exporters of Trastuzumab to United States are BIOCON BIOLOGICS INDIA LIMITED, LOKA BIOSCIENCES PRIVATE LIMITED, INTAS PHARMACEUTICALS LIMITED. BIOCON BIOLOGICS INDIA LIMITED holds the largest market share at approximately 98% of total trade value on this route.
Q What is the total value of Trastuzumab exports from India to United States?
India exports Trastuzumab to United States worth approximately $3.0M USD across 26 recorded shipments. The average value per shipment is $115.0K USD.
Q Which ports does India use to ship Trastuzumab to United States?
The most active port of origin is AHEMDABAD AIR with 12 shipments. Indian exporters primarily use sea freight for this route, with 70% of shipments going by sea and 18% by air.
Q How long does shipping take from India to United States for Trastuzumab?
The average transit time for Trastuzumab shipments from India to United States is approximately 15 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to United States Trastuzumab trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 11.1% with demand growth tracking at 11.8%. The route is ranked #18 among India's top Trastuzumab export destinations globally.
Q How many suppliers are active on the India to United States Trastuzumab route?
There are currently 5 active Indian suppliers exporting Trastuzumab to United States. The market is moderately concentrated with BIOCON BIOLOGICS INDIA LIMITED accounting for 98% of total shipment value.
Q Who are the main importers of Trastuzumab from India in United States?
The leading importers of Indian Trastuzumab in United States include XXOSIXXLARXXNEWXX LIXXTED, KBDNA INC, PROLYNX INC, CHARLES RIVER LABORATORIES, INC., CHARLES RIVER LABORATORIES INC. XXOSIXXLARXXNEWXX LIXXTED is the largest buyer with 5 shipments worth $2.9M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Trastuzumab.
- 2.Supplier/Buyer Matching: 5 Indian exporters and 9 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 26 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
26 Verified Shipments
5 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists